<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Vitiligo on Tenu Tech Brief</title>
    <link>https://cluster-site.onrender.com/tags/vitiligo/</link>
    <description>Recent content in Vitiligo on Tenu Tech Brief</description>
    <generator>Hugo -- 0.146.0</generator>
    <language>en-us</language>
    <lastBuildDate>Wed, 25 Feb 2026 07:59:10 +0000</lastBuildDate>
    <atom:link href="https://cluster-site.onrender.com/tags/vitiligo/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Landmark vitiligo cream targets immune cells that disrupt pigmentation</title>
      <link>https://cluster-site.onrender.com/posts/landmark-vitiligo-cream-targets-immune-cells-that-disrupt-pigmentation/</link>
      <pubDate>Tue, 24 Feb 2026 13:52:44 +0000</pubDate>
      <guid>https://cluster-site.onrender.com/posts/landmark-vitiligo-cream-targets-immune-cells-that-disrupt-pigmentation/</guid>
      <description>• Vitiligo involves paler, less-pigmented skin patchesGetty Images Vitiligo involves paler, less-pigmented skin patches Getty Images A first-of-its-kind cream that targets the unde</description>
    </item>
  </channel>
</rss>
